A GLOBAL COMPANY INTEGRATED IN THE ANIMAL AND HUMAN HEALTH INDUSTRIES WITH A DIVERSIFIED PORTFOLIO OF PRODUCTS AND BUSINESSES AND A BROAD CLIENT BASE OF TOP-TIER CUSTOMERS WITH WHOM IT HAS A LONG-LASTING TRUSTED RELATIONSHIP.
OTHER RELEVANT INFORMATION
04/09/2025 17:12 LABIANA Other Relevant Information: Transactions carried out by executives. LABIANA reports on the details of the share sale transactions of LABIANA carried out by Maria Jesús Crespo Domínguez, R&D and Regulatory Affairs Director of LABIANA, on September 1st. View pdf. (148 KB)
29/08/2025 LABIANA Other Relevant Information: Transactions carried out by executives. LABIANA reports on the details of the share sale transactions of LABIANA carried out by Antonio José Ortiz Romera, Animal Health Commercial Director of LABIANA, between August 26th and 27th, 2025. View pdf. (148 KB)
01/08/2025 LABIANA Other Relevant Information: On business and financial situation. LABIANA presents the preliminary figures of the unaudited consolidated income statement for the first half of 2025. View pdf. (197 KB)
28/07/2025 LABIANA Other Relevant Information: Other relevant information. LABIANA reports on the change of secretary of the Board of Directors. View pdf. (216 KB)
———- View more ———-
On December 27, 2024, LABIANA Other Relevant Information: Operations carried out by executives. LABIANA reports the details of the share sale operations of LABIANA carried out by ORTEGA FARMING S.L.U., represented by Mr. Manuel Ramos Ortega, CEO of LABIANA, on December 27, 2024. View pdf (148 KB)
On December 27, 2024, LABIANA Other Relevant Information: Other relevant information. LABIANA reports on the agreement to enter the capital of the Family Office ANCESMEI. View pdf (52 KB)
On December 24, 2024, LABIANA Other Relevant Information: Share buyback programs, stabilization, and treasury stock. LABIANA reports the details of the share sale operations of LABIANA carried out by Ignacio Yáñez Minondo, a member of LABIANA’s Board of Directors, between December 20, 2024, and December 23, 2024. View pdf (148 KB)
17/12/2024 LABIANA Other Relevant Information: Transactions carried out by executives. LABIANA reports the details of the share sales transactions of LABIANA carried out by Antonio José Ortiz Romera, Commercial Director of Animal Health at LABIANA, on December 11, 2024. View pdf (147 KB)
———- View more ———-
22/12/2023 LABIANA Other Relevant Information: Share buyback programs, stabilization, and treasury stock. LABIANA communicates the details of the share buyback transactions carried out by the Company between December 21, 2023, and December 22, 2023, in execution of the Share Buyback Program approved by the Board of Directors in the session of September 25, 2023. Ver pdf (135 KB)
22/12/2023 LABIANA Other Relevant Information: Other relevant information. The Company reports the agreements adopted at the Extraordinary General Shareholders’ Meeting held on December 22, 2023.. Ver pdf (235 KB)
19/12/2023 LABIANA Other Relevant Information: Share buyback programs, stabilization, and treasury stock. LABIANA reports the details of the share buyback transactions carried out by the Company on December 15, 2023, in execution of the Share Buyback Program approved by the Board of Directors in the session of September 25, 2023. Ver pdf (132 KB)
23/11/2023 LABIANA Other Relevant Information: Call for a Meeting or Assembly. According to the OIR published by LABIANA on November 22, 2023, the company announced that by agreement of the Board of Directors of LABIANA, the shareholders are summoned to the Extraordinary General Meeting of Shareholders, to be held on December 22, 2023. Ver pdf (183 KB)
———- Ver más ———-
31/10/2022 LABIANA OTHER RELEVANT INFORMATION: Information on forecasts published on October 28, 2022. Ver pdf (140 KB)
31/10/2022 LABIANA OTHER RELEVANT INFORMATION: Labiana announces the launch of a new veterinary medicine. Ver pdf (344 KB)
28/10/2022 LABIANA OTHER RELEVANT INFORMATION: Communication of future update of comparative figures for 2021 in the profit and loss account. Ver pdf (104 KB)
28/10/2022 LABIANA OTHER RELEVANT INFORMATION: Semiannual financial and audit/review reports. Financial information for the first half of 2022. Ver pdf (17 MB)
———- Ver más ———-
INVESTOR RELATIONS
Avenida Europa, 34 1ºD
28023 Pozuelo de Alarcón (Madrid)
Phone: (+34) 91 991 26 28